This filing is a routine awareness event with no financial or operational catalysts. Monitor future filings for revenue updates, reimbursement developments, or clinical trial results for CyPath Lung.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $3.03entry
- T+1 · 6d ago −3.96%α −2.19% · $2.91
- T+4 · todayOpen
- T+5 · in 12h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
bioAffinity Technologies filed an 8-K announcing its participation in the Lung Cancer Initiative of North Carolina's 'Battle of the Blues' event on November 5, 2026, to promote its CyPath Lung test during National Lung Cancer Awareness Month. The filing is a routine press release with no financial data, material agreements, or regulatory events.
Key Facts
- bioAffinity Technologies will participate in the Lung Cancer Initiative of North Carolina's Battle of the Blues event on November 5, 2026.
- The event highlights advancements in lung cancer diagnostics and therapies.
- The company's CyPath Lung test is a noninvasive, AI-driven assay for early lung cancer detection.
- CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy, and 99% negative predictive value in a published clinical trial.
- No financial figures, guidance, or material business developments were disclosed in the filing.
Financial Impact
No financial impact disclosed; the filing is a routine awareness event announcement.
Risk Factors
- No material financial or operational information was provided in this filing.
- Forward-looking statements in the press release are subject to risks including changes to event schedule, replication of case study results, and that earlier detection may not improve outcomes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-049188 |
| Exhibit: ex99-1.htm | 0001493152-26-049188 |
| Document: 0001493152-26-049188-index-headers.html | 0001493152-26-049188 |
| Document: 0001493152-26-049188-index.html | 0001493152-26-049188 |
| Document: 0001493152-26-049188.txt | 0001493152-26-049188 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 1d ago | 424B5 | $3.04 | awaiting T+60 | awaiting T+60 | $2.93 (+3.60%) |
Nov 2, 2026 2d ago | 424B5 | $3.19 | awaiting T+60 | awaiting T+60 | $2.93 (+8.15%) |
Oct 29, 2026 6d ago | 8-K | $3.03 | awaiting T+60 | awaiting T+60 | $2.93 (−3.30%) |
Oct 23, 2026 12d ago | DEF 14A | $2.83 | awaiting T+60 | awaiting T+60 | $2.93 (+3.53%) |
Oct 15, 2026 20d ago | 8-K | $3.96 | awaiting T+60 | awaiting T+60 | $2.93 (−26.01%) |
Oct 13, 2026 22d ago | 8-K | $3.63 | awaiting T+60 | awaiting T+60 | $2.93 (−19.17%) |
Oct 9, 2026 26d ago | 8-K | $3.90 | awaiting T+60 | awaiting T+60 | $2.93 (+24.87%) |
Oct 9, 2026 26d ago | 424B5 | $4.73 | awaiting T+60 | awaiting T+60 | $2.93 (+37.99%) |
Oct 9, 2026 26d ago | 424B5 | $4.73 | awaiting T+60 | awaiting T+60 | $2.93 (−37.99%) |
Oct 8, 2026 27d ago | 8-K | $5.64 | awaiting T+60 | awaiting T+60 | $2.93 (−48.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers